Aggressive multiple sclerosisA small proportion of people who develop multiple sclerosis experience a rapid progression of their disease […]

The drug targets all solid tumours with the NTRK gene fusions

The ‘landmark’ decision invalidates Regeneron’s patent claims covering its genetically modified mice

The trial will see around 300 people given the vaccine plus a booster shot up to four weeks […]

The move provides the opportunity to conduct essential post-marketing surveillance

The triple therapy is currently under review for COPD in both the EU and US

Bayer inks largest settlement in pharma history with $10B Roundup deal kblankenship Wed, 06/24/2020 – 13:49

Regeneron vows to fight DOJ lawsuit alleging charity donations were Eylea kickbacks esagonowsky Wed, 06/24/2020 – 16:23

Merck treads on Sanofi, Regeneron’s turf with Keytruda’s latest skin cancer OK chelfand Wed, 06/24/2020 – 16:43

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT